NCT03021408

Brief Summary

Evaluation of the effectiveness of three different approaches for the rehabilitation of gait in patients with PD within a multidisciplinary, intensive rehabilitation treatment (MIRT).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

January 7, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 13, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
Last Updated

January 13, 2017

Status Verified

January 1, 2017

Enrollment Period

4 months

First QC Date

January 7, 2017

Last Update Submit

January 12, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • 6-minute walking test (6MWT)

    Patient is first familiarized with the test by letting him/her go once forward and backward along a straight 15-m line on the ground in a gymnasium. Then, after 15 minutes rest, he/she is instructed to walk from end to end of the line for 6 minutes and to cover as much distance as possible. No encouragement is offered during the test and no cues are used.

    4 weeks

Secondary Outcomes (3)

  • Average length of right and left steps

    4 weeks

  • Coefficient of variance

    4 weeks

  • Step cycle

    4 weeks

Study Arms (3)

MIRT + Treadmill

EXPERIMENTAL

In the context of MIRT, the gait training in this group will be performed by using a treadmill without cues.

Other: MIRT + Treadmill

MIRT + Treadmill Plus

EXPERIMENTAL

In the context of MIRT, the gait training in this group will be performed by using a treadmill with visual and auditory cues.

Other: MIRT + Treadmill Plus

MIRT + Virtual Reality

EXPERIMENTAL

In the context of MIRT, the gait training in this group will be performed by using Virtual Reality with enhanced perceptions (visual, auditory, and haptic inputs).

Other: MIRT + Virtual Reality

Interventions

PD patients will undergo a 4-week MIRT. All patients in the MIRT+Treadmill Plus group will undergo 10-minutes treadmill training twice per day, 5 times a week, for 4 weeks.

MIRT + Treadmill

PD patients will undergo a 4-week MIRT. All patients in the MIRT+Treadmill Plus group will undergo 10-minutes treadmill-plus training (with visual and auditory cues) twice per day, 5 times a week, for 4 weeks.

MIRT + Treadmill Plus

PD patients will undergo a 4-week MIRT. All patients in the MIRT+Virtual Reality (VR) group will undergo 10-minutes VR training with enhanced perceptions (visual, auditory, and haptic inputs), twice per day, 5 times a week, for 4 weeks.

MIRT + Virtual Reality

Eligibility Criteria

Age50 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of "probable" idiopathic Parkinson's disease according to Gelb et al (Gelb, 1999);
  • Mild to moderate stage of disease (stage 2-3) according to Hoehn \& Yahr scale;
  • Ability to walk on treadmill;
  • Visual and hearing capacity sufficient to perceive the cues;
  • No cognitive impairment (Mini-Mental State Examination score ≥ 26);
  • Stable pharmacological treatment since 2 weeks before admission and during rehabilitation;

You may not qualify if:

  • Diagnosis of atypical or vascular Parkinsonism;
  • Occurrence of cardiovascular, orthopaedic, peripheral nerves, musculoskeletal and vestibular disorders which could affect patient's locomotion or balance;
  • Neuropsychiatric disturbances;
  • Severe dyskinesia;
  • Severe freezing of gait;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

"Moriggia-Pelascini" Hospital

Gravedona Ed Uniti, Como, 22015, Italy

RECRUITING

MeSH Terms

Conditions

Gait Disorders, Neurologic

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Frazzitta Giuseppe, MD

    "Moriggia-Pelascini" Hospital

    STUDY DIRECTOR

Central Study Contacts

Davide Ferrazzoli, MD

CONTACT

Ilaria Zivi, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 7, 2017

First Posted

January 13, 2017

Study Start

January 1, 2017

Primary Completion

May 1, 2017

Study Completion

May 1, 2017

Last Updated

January 13, 2017

Record last verified: 2017-01

Data Sharing

IPD Sharing
Will not share

Locations